Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders - An individual patient data meta-analysis

Mattia Campana,Vladislav Yakimov,Joanna Moussiopoulou,Isabel Maurus,Lisa Löhrs,Florian Raabe,Iris Jäger,Matin Mortazavi,Michael E Benros,Rose Jeppesen,Gerd Meyer Zu Hörste,Michael Heming,Eloi Giné-Servén,Javier Labad,Ester Boix,Belinda Lennox,Ksenija Yeeles,Johann Steiner,Gabriela Meyer-Lotz,Henrik Dobrowolny,Berend Malchow,Niels Hansen,Peter Falkai,Spyridon Siafis,Stefan Leucht,Sean Halstead,Nicola Warren,Dan Siskind,Wolfgang Strube,Alkomiet Hasan,Elias Wagner,Michael E. Benros,Gerd Meyer zu Hörste
DOI: https://doi.org/10.1016/j.bbi.2024.04.011
IF: 19.227
2024-04-14
Brain Behavior and Immunity
Abstract:Neuroinflammation and blood-cerebrospinal fluid barrier (BCB) disruption could be key elements in schizophrenia-spectrum disorderś(SSDs) etiology and symptom modulation. We present the largest two-stage individual patient data (IPD) meta-analysis, investigating the association of BCB disruption and cerebrospinal fluid (CSF) alterations with symptom severity in first-episode psychosis (FEP) and recent onset psychotic disorder (ROP) individuals, with a focus on sex-related differences. Data was...
immunology,neurosciences,psychiatry
What problem does this paper attempt to address?